Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 6/20 | 0.56 |
| ▸ | MAPT | P10636 | 11/20 | 0.53 |
| ▸ | GAA | P10253 | 5/20 | 0.53 |
| ▸ | RAB9A | P51151 | 5/20 | 0.53 |
| ▸ | NPC1 | O15118 | 4/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | GLA | P06280 | 3/20 | 0.53 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.51 |
| ▸ | APP | P05067 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25137597 | 0.86 | MAPT (0.53) | SMN1; SMN2MAPTGAARAB9ANPC1 | |
| SCHEMBL12312850 | 0.83 | MAPT (0.54) | SMN1; SMN2MAPTGAARAB9ANPC1 | |
| SCHEMBL29409281 | 0.79 | HTT (0.56) | MAPTGAAAPPCA1CA2 | |
| SCHEMBL20681327 | 0.79 | DYRK1A (0.42) | MAPTKDM4EAPPALDH1A1MEN1 | |
| SCHEMBL12312853 | 0.79 | NPC1 (0.56) | SMN1; SMN2MAPTGAARAB9ANPC1 | |
| SCHEMBL19190176 | 0.79 | APP (0.44) | SMN1; SMN2MAPTGAARAB9ANPC1 | |
| SCHEMBL140656 | 0.79 | HTT (0.56) | MAPTGAAAPPCA1CA2 | |
| SCHEMBL730573 | 0.79 | RAB9A (0.49) | SMN1; SMN2MAPTRAB9ANPC1APP | |
| SCHEMBL12872411 | 0.79 | RAB9A (0.56) | SMN1; SMN2MAPTGAARAB9ANPC1 | |
| SCHEMBL7548821 | 0.79 | GFER (0.56) | SMN1; SMN2MAPTGAARAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060052-A | Method for chemically modifying nano antibody by site specificity and application thereof | 哈尔滨工业大学 | 2026-05-19 | — | — | CN | claimed |
| CN-117462675-B | Preparation method and application of engineering bacterium loaded functionalized melanin nano-system compound | 郑州大学 | 2026-05-12 | — | — | CN | claimed |
| CN-118490852-B | Intracellular-constructed legumain-responded PET/MR bimodal molecular probe and application thereof | 安徽医科大学第一附属医院 | 2025-05-16 | — | — | CN | claimed |
| CN-118490852-A | Intracellular-constructed legumain-responded PET/MR bimodal molecular probe and application thereof | 安徽医科大学第一附属医院 | 2024-08-16 | — | — | CN | claimed |
| CN-117462675-A | Preparation method and application of engineering bacterium loaded functionalized melanin nano-system compound | 郑州大学 | 2024-01-30 | — | — | CN | claimed |
| CN-116297413-A | Application of amino luciferin derivative bioluminescence probe in malaria diagnosis | 山东大学第二医院 | 2023-06-23 | — | — | CN | claimed |
| US-20230105741-A1 | PHOTOREACTIVE AND CLEAVABLE PROBES FOR TAGGING BIOMOLECULES | Syncell (Taiwan) Inc. (TW) | 2023-04-06 | — | — | US | claimed |
| CN-109824622-B | Prodrug forming nano structure in cell to kill cancer cell and its prepn | 中国科学技术大学 | 2022-12-30 | — | — | CN | claimed |
| CN-115141253-A | T for CTSB response constructed in cells 2 Small molecule magnetic resonance contrast agent and preparation method thereof | 中国科学技术大学 | 2022-10-04 | — | — | CN | claimed |
| CN-111420053-B | Multifunctional magnetic nanoparticle compound capable of intracellular aggregation and preparation method thereof | 珠海市人民医院 | 2022-09-09 | — | — | CN | claimed |
| US-20180079906-A1 | AZACYANINE DYES AND USE THEREOF | Ecole polytechnique fédérale de Lausanne (EPFL) (CH) | 2018-03-22 | — | — | US | claimed |
| CN-106967152-A | Compound that a kind of fluorine 18 is marked and preparation method and application | 江苏省原子医学研究所 | 2017-07-21 | — | — | CN | claimed |
| WO-2014057139-A2 | PRECURSOR MOLECULE FOR THE SYNTHESIS OF D-LUCIFERIN | ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL) (CH) | 2014-04-17 | — | — | WO | claimed |
| EP-2719703-A1 | Precursor molecule for the synthesis of D-luciferin | Ecole Polytechnique Fédérale de Lausanne (EPFL) (CH) | 2014-04-16 | — | — | EP | claimed |
| US-8586759-B2 | Methods and systems for synthesis of a D-aminoluciferin precursor and related compounds | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (US) | 2013-11-19 | — | — | US | claimed |
| US-20110224442-A1 | METHODS AND SYSTEMS FOR SYNTHESIS OF A D-AMINOLUCIFERIN PRECURSOR AND RELATED COMPOUNDS | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC (LLNS) | 2011-09-15 | — | — | US | claimed |
| US-20110213124-A1 | METHODS AND SYSTEMS FOR SYNTHESIS OF A D-AMINOLUCIFERIN PRECURSOR AND RELATED COMPOUNDS | LAWRENCE LIVERMORE NATIONAL SECURITY, LLC | 2011-09-01 | — | — | US | claimed |
| EP-0300001-B1 | AMINOLUCIFERINES, PROCESS FOR PRODUCING SAME AND USE THEREOF | Geiger, Reinhard, Dr. (DE) | 1992-10-28 | — | — | EP | claimed |
| EP-0300001-A1 | AMINOLUCIFERINES, PROCESS FOR PRODUCING SAME AND USE THEREOF. | GEIGER REINHARD DR (DE) | 1989-01-25 | — | — | EP | claimed |
| WO-1988005434-A1 | AMINOLUCIFERINES, PROCESS FOR PRODUCING SAME AND USE THEREOF | GEIGER REINHARD (DE) | 1988-07-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224442-A1 | METHODS AND SYSTEMS FOR SYNTHESIS OF A D-AMINOLUCIFERIN PRECURSOR AND RELATED COMPOUNDS | HCCS, HLCS, GLUL | SMN1; SMN2 4724/4885MAPT 4518/4885GAA 1123/4885 |
| US-20110213124-A1 | METHODS AND SYSTEMS FOR SYNTHESIS OF A D-AMINOLUCIFERIN PRECURSOR AND RELATED COMPOUNDS | HCCS, HLCS, GLUL | SMN1; SMN2 4724/4885MAPT 4518/4885GAA 1123/4885 |
| US-20180079906-A1 | AZACYANINE DYES AND USE THEREOF | INMT, AZI2, MYADM | SMN1; SMN2 2777/4885MAPT 3491/4885GAA 2988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.